Skip to content
    GL
    Earnings call· Mar 2026(Q1 FY26)

    GLOBE LIFE Q1 FY26 earnings call GL

    Apr 23, 2026 Source

    Executive summary

    Globe Life Inc. Q1 FY26 — Strong Operating Income Growth and Increased Share Buyback

    Globe Life Inc. delivered robust Q1 FY26 results, marked by strong double-digit operating income per share growth and significant health sales expansion, supported by strategic investments and favorable market dynamics in Medicare supplement. Despite some agent retention challenges at American Income Life and elevated lapse rates, the company increased its share repurchase guidance, reflecting confidence in its capital generation and resilient business model. Management anticipates continued benefits from AI adoption and favorable mortality trends.

    Highlights

    5

    • Net operating income per share increased 12% to $3.43, marking double-digit growth in 7 of the last 8 quarters.

    • Total premium revenue grew 6% YoY, with full-year guidance of approximately 7% growth.

    • Total health net sales grew 58% YoY, driven by strong performance in United American and Family Heritage.

    • Share repurchases accelerated to $205 million in Q1 at an average price of $141.24, with full-year guidance increased to $560M-$610M.

    • Book value per share (ex-AOCI) increased 12% to $98.56.

    Concerns

    3

    • American Income Life's average producing agent count decreased 4% YoY due to a decline in new agent retention.

    • Life premiums for the direct-to-consumer division were down approximately 1% YoY.

    • Lapse rates, particularly for first-year policies at American Income Life, remained elevated compared to pre-pandemic levels due to economic stress.

    Guidance & targets

    37
    CategoryTargetConfidence
    Total premium revenue growth
    approximately 7%
    high materiality
    High
    Life premium revenue growth
    between 3% and 3.5%
    medium materiality
    High
    Life underwriting margin as a percent of premium
    between 42% and 45%
    medium materiality
    High
    Life underwriting margin as a percent of premium
    around 41%
    medium materiality
    High
    Health premium revenue growth
    in the range of 14% to 17%
    medium materiality
    High
    Health underwriting margin as a percent of premium
    between 23% and 27%
    medium materiality
    High
    Administrative expenses as a percent of premium
    approximately 7.3%
    medium materiality
    High
    Average producing agent count growth (American Income Life)
    low single-digit growth
    medium materiality
    Medium
    Average producing agent count growth (Liberty National)
    low double-digit growth
    medium materiality
    High
    Average producing agent count growth (Family Heritage)
    low double-digit growth
    medium materiality
    High
    Life sales growth (American Income)
    mid-single-digit growth
    medium materiality
    High
    Life sales growth (Liberty National)
    low double-digit growth
    medium materiality
    High
    Life sales growth (Direct-to-Consumer)
    low single-digit growth
    medium materiality
    High
    Health sales growth (Liberty National)
    mid-single-digit growth
    medium materiality
    High
    Health sales growth (Family Heritage)
    low double-digit growth
    medium materiality
    High
    Health sales growth (United American)
    high teens growth
    medium materiality
    High
    Net investment income growth
    around 4%
    medium materiality
    High
    Required interest growth
    around 4%
    medium materiality
    High
    Excess investment income growth
    between 4% and 4.5%
    medium materiality
    High
    Average yield earned on long-term investments
    between 5.45% and 5.5%
    medium materiality
    High
    Earned yield for fixed maturity portfolio
    around 5.3%
    medium materiality
    High
    Fixed maturities investment acquisitions
    approximately $800 million to $900 million
    medium materiality
    High
    Total investment acquisitions (all asset classes)
    approximately $1.1 billion to $1.2 billion
    medium materiality
    High
    Parent liquid assets
    within our target range of $50 million to $60 million
    medium materiality
    High
    Shareholder dividend payments
    approximately $90 million
    high materiality
    High
    Share repurchases
    $560 million to $610 million
    high materiality
    High
    Consolidated company action level RBC ratio
    in the range of 300% to 320%
    high materiality
    High
    Net operating earnings per diluted share
    in the range of $15.40 to $15.90
    high materiality
    High
    Estimated pre-tax benefit from anticipated assumption updates
    $70 million to $110 million
    high materiality
    High
    Life margin as a percent of premium
    in the range of 49% to 54%
    high materiality
    High
    Normalized life underwriting margin as a percent of premium
    approximately 41%
    medium materiality
    High
    United American health margin as a percentage of premium
    in the range of 8% to 9%
    medium materiality
    High
    Average health underwriting margin as a percent of premium
    approximately 10%
    medium materiality
    High
    Normalized EPS growth (excluding assumption updates)
    approximately 11%
    high materiality
    High
    3-year compound annual growth rate of normalized EPS
    11.5%
    high materiality
    High
    Administrative expense ratio
    closer to 7%
    medium materiality
    Medium
    Bermuda entity filing
    filing for a simple jurisdiction
    medium materiality
    High

    Segment performance

    5
    SegmentRevenueYoYQoQMargin
    American Income Life
    Life premiums and underwriting margin increased. Net life sales grew due to improved agent productivity, despite a decline in average producing agent count primarily from lower new agent retention. Compensation adjustments implemented in Q2 are expected to positively impact agent count in H2.
    Life underwriting margin: $209MNet life sales: $101MNet life sales growth: 3% YoYAverage producing agent count: 11,064Average producing agent count growth: -4% YoY
    		$459M5%—$209M
    Liberty National
    Life premiums and underwriting margin increased. Strong net life sales growth was driven by agent count growth. Net health sales decreased as more emphasis was placed on the life business. Agent count growth was robust.
    Life underwriting margin: $35MNet life sales: $25MNet life sales growth: 13% YoYNet health sales: $7MNet health sales growth: -3% YoYAverage producing agent count: 4,031Average producing agent count growth: 9% YoY
    		$100M4%—$35M
    Family Heritage
    Health premiums and underwriting margin increased. Net health sales grew significantly due to increases in agent count and productivity. Strong agent count growth continues from focus on recruiting and growing middle management.
    Health underwriting margin: $44MNet health sales: $33MNet health sales growth: 22% YoYAverage producing agent count: 1,561Average producing agent count growth: 10% YoY
    		$123M10%—$44M
    Direct-to-Consumer
    Life premiums were down slightly, but life underwriting margin increased significantly. Net life sales grew. The division's value extends beyond DTC sales through support for agencies, with improved conversion of shared leads leading to margin improvement and increased lead generation investment.
    Life underwriting margin: $74MLife underwriting margin growth: 15% YoYNet life sales: $27MNet life sales growth: 8% YoY
    		$244M-1%—$74M
    United American General Agency
    Health premiums increased substantially. Health underwriting margin and net health sales saw significant increases. Sales were strong across Medicare supplement and other businesses, benefiting from the movement of Medicare beneficiaries from Medicare Advantage to Medicare supplement and group worksite business development.
    Health underwriting margin: $5MHealth underwriting margin increase: ~$4M YoYNet health sales: $62MNet health sales increase: ~$34M YoY
    		$194M22%—$5M

    Operational metrics

    46
    Net income
    $271Mup from $255M YoY
    Q1 FY26
    Net income per share
    $3.39up from $3.01 YoY
    Q1 FY26
    Net operating income
    $274M
    Q1 FY26
    Net operating income per share
    $3.43up 12% YoY from $3.07
    Q1 FY26

    Double-digit growth in 7 of the last 8 quarters.

    Return on equity (GAAP)
    17.9%
    through March 31, 2026
    Return on equity (ex-AOCI)
    14%
    as of March 31, 2026
    Book value per share (ex-AOCI)
    $98.56up 12% YoY
    as of March 31, 2026
    Total premium revenue growth
    6%YoY
    Q1 FY26
    Life underwriting margin as % of premium
    41%same YoY
    Q1 FY26
    Health underwriting margin as % of premium
    23%same YoY
    Q1 FY26
    Administrative expenses
    $94Mup approximately 8% YoY
    Q1 FY26
    Administrative expenses as % of premium
    7.4%
    Q1 FY26
    Total Life net sales growth
    6%YoY
    Q1 FY26
    Total Health net sales growth
    58%YoY
    Q1 FY26
    Excess investment income
    $37Mup approximately $1M YoY
    Q1 FY26
    Net investment income
    $290Mup 3% YoY
    Q1 FY26
    Average invested assets growth
    2%YoY
    Q1 FY26
    Required interest growth
    3%YoY
    Q1 FY26
    Average policy liabilities growth
    4%YoY
    Q1 FY26
    Fixed maturities invested
    $419M
    Q1 FY26

    Primarily in industrial and financial sectors.

    Commercial mortgage loans and other long-term investments
    $147M
    Q1 FY26

    With debt-like characteristics, expected to produce additional cash yield over fixed maturity investments.

    Earned yield on total long-term invested assets
    5.5%
    Q1 FY26

    Includes fixed maturity, commercial mortgage loans, and other long-term nonfixed matured investments.

    Invested assets
    $22B
    Q1 FY26
    Fixed maturities (amortized cost)
    $19.1B
    Q1 FY26
    Investment grade fixed maturities
    $18.6B
    Q1 FY26
    Total fixed maturity portfolio rating
    A-same YoY
    Q1 FY26
    Senior direct lending & asset-based finance exposure
    1%
    Q1 FY26

    Of total investment portfolio.

    Traditional private placements exposure
    approximately 1%
    Q1 FY26

    Of total investment portfolio.

    Net underlying loss position (fixed maturities)
    $1.6B
    Q1 FY26

    Due to current market rates being higher than book yield on holdings; primarily interest rate driven and relates to bonds with maturities beyond 10 years.

    BBB bonds as % of fixed maturity portfolio
    41%down from 45% YoY
    Q1 FY26

    Lowest level since 2003.

    Low investment-grade bonds
    $511Mcompared to $506M YoY
    Q1 FY26
    Below investment-grade bonds as % of total fixed maturity
    2.7%consistent with year-end 2025
    Q1 FY26
    Total exposure (BBB + below investment-grade) as % of equity (ex-AOCI)
    lowest in over 25 years
    Q1 FY26

    Among the lowest of peers due to low overall leverage.

    Parent liquid assets
    $85M
    Q1 FY26

    Ended the quarter; began year with $80M.

    Shares repurchased
    1.4M
    Q1 FY26
    Cost of share repurchases
    $205M
    Q1 FY26
    Average share price for repurchases
    $141.24
    Q1 FY26
    Shareholder dividend payments
    $20M
    Q1 FY26
    Total capital returned to shareholders
    $225M
    Q1 FY26

    Includes share repurchases and dividends.

    Excess capital above minimum RBC target
    $95M
    YE25

    Above 300% minimum target capital level for consolidated RBC ratio of U.S. subsidiaries.

    Life policy obligations as % of premium
    35.4%declined from 36.3% YoY
    Q1 FY26

    Slightly favorable to management estimates, consistent with continued favorable mortality trends.

    Health policy obligations as % of premium
    56.3%compared to 55.6% YoY
    Q1 FY26

    Consistent with management estimates for the quarter, reflecting Q1 claims seasonality at United American.

    Additional premium from approved rate increases (Medicare supplement)
    $65M
    FY26

    Primarily in the last 3 quarters of the year.

    Normalized EPS growth (ex-assumption updates)
    approximately 11%
    FY26

    At the midpoint of guidance, removes the impact of assumption updates in both 2025 and 2026.

    3-year compound annual growth rate of normalized EPS
    11.5%
    3-year

    At the midpoint of guidance.

    Excess cash flow (parent)
    $650M-$700Mupdated from $600M-$700M
    FY26

    Primarily results from dividends received by the parent from subsidiaries less interest paid on debt.

    Industry KPIs

    8
    MetricValueDetails
    Capital returns$205M buyback, $20M dividendsUSD
    ROE operating ROE14%%
    Book value per share$98.56USD
    Net investment income$290MUSD
    Retention persistencyvery resilient
    Life specific when presentLife underwriting margin 41% of premium (Q1 FY26); Q3 FY26 life margin 49%-54% of premium (due to assumption updates)%
    Net premiums written earned$853M Life, $417M HealthUSD
    Statutory regulatory capital316%%

    Risks & headwinds

    3
    Elevated Lapse RatesFY26

    elevated for '26 versus the pre-pandemic

    Mitigation: Management implemented compensation adjustments for middle management in Q2 FY26 to emphasize new agent recruiting and retention, expecting positive impact in H2 FY26.

    Agent Retention ChallengesQ1 FY26

    down 4% from a year ago

    Mitigation: Compensation adjustments implemented in Q2 FY26 are designed to improve new agent recruiting and retention, with expected positive impact in H2 FY26.

    High Hurdle for United American Sales GrowthQ4 FY26

    doubled our sales last year

    Mitigation: Management acknowledges the high hurdle but expects Q2 and Q3 to still show slight improvements over last year, and continues to benefit from Medicare supplement tailwinds.

    What to watch in Q2 FY26

    5

    American Income Life agent count growth

    H2 FY26
    CurrentDown 4% YoY (Q1 FY26)
    TargetLow single-digit growth (FY26 guidance)

    Why it matters

    Agent count growth is crucial for long-term sales growth and is being addressed by recent compensation adjustments.

    We expect these adjustments to have a positive impact on our overall agent count during the second half of this year.

    Q&A highlights

    7

    What's driving elevated lapse rates, especially at AIL, and is it macro-driven or distribution-related? What's the outlook?

    Lapse rates are expected to remain elevated for FY26 due to economic stress, consistent with prior years. AIL's Q1 lapse rates were high but considered a fluctuation. Management noted that growth in worksite business and DTC internet sales (which have historically higher lapse rates) also contribute. The resiliency of policies after a few years in the budget is high.

    “Yes, we do expect lapse rates to remain elevated for '26 versus the pre-pandemic. And we've seen that over the past few years as well. And I think the experience we expect is going to be more consistent with last year, given the economic stress that is on our policyholders from the current economic environment and overall price inflation.”

    asked by Jack Matten · answered by Thomas Kalmbach

    2 min read5 chapters

    Detailed Narrative

    01

    AI Implementation and Benefits

    Globe Life is actively implementing AI applications across its high-volume business operations, including policy applications, customer service, and claims processing. Management expects these initiatives to drive administrative expense ratios down from 7.4% to closer to 7% over the next few years, while also enhancing distribution and underwriting activities. The company is optimistic about enterprise-wide benefits from AI, leveraging its deep experience in online advertising and participation in beta programs with major platforms.

    02

    Mortality Trends and Assumption Updates

    The company reported continued favorable mortality trends, which are informing the anticipated Q3 FY26 assumption updates, expected to provide a $70M-$110M pre-tax benefit. These updates are largely driven by improvements in mortality claims, particularly in non-medical deaths (suicide, homicide, drug/alcohol abuse), and are expected to reset long-term underwriting margins to a higher, more stable level. Management noted that new weight-loss treatments and increased healthcare utilization post-COVID could further positively impact future mortality experience.

    03

    Agent Count and Productivity Dynamics

    While Liberty National and Family Heritage showed strong agent count growth (9% and 10% YoY, respectively), American Income Life's agent count declined 4% YoY due to new agent retention challenges. Management implemented compensation adjustments in Q2 FY26 to re-emphasize new agent recruiting and retention, expecting a positive impact in H2 FY26. Despite this, American Income Life saw improved agent productivity, contributing to 3% net life sales growth.

    04

    Investment Portfolio Strategy

    Globe Life maintains a conservative investment philosophy, with 95% of its $22 billion invested assets in fixed maturities and commercial mortgage loans. The fixed maturity portfolio is 97.3% investment grade (average rating A-), with BBB-rated bonds at their lowest level since 2003 (41%). The company holds investments to maturity, mitigating concerns about a $1.6 billion net unrealized loss position, which is primarily interest-rate driven and concentrated in long-dated bonds.

    05

    Capital Management and Shareholder Returns

    The company ended Q1 FY26 with $85 million in parent liquid assets and returned $225 million to shareholders through $205 million in share repurchases and $20 million in dividends. Share repurchase guidance for FY26 was increased to $560M-$610M, reflecting higher excess cash flow generation ($650M-$700M range) and opportunistic buying during market dips. The consolidated RBC ratio of U.S. subsidiaries was 316% at year-end 2025, within the target range of 300%-320%.

    AI-generated summary of the company’s earnings call. Not investment advice.